The Genotoxic Effects in Lymphocyte Cultures of Children Treated with Radiosynovectomy by Using Yttrium-90 Citrate Colloid

Abstract

Stromal medication with (32)P-CP during a cardiac-esophageal carcinoma resection is a simple and safe procedure for controlling postoperative lymphatic metastasis and revealed a very fair clinical effectiveness in improving both medium- and long-term survival rates in patients.

Long‐term outcomes in haemophilic synovitis after radiosynovectomy using rhenium‐186: a single‐centre experience

“…Radiosynovectomy has been performed successfully for more than 10 years in our hospital. Our previously reported experience and review of the literature have demonstrated that radiosynovectomy is a safe and effective treatment for patients with haemophilic synovitis, even during early years of life [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16]. Furthermore, this study revealed that patients' mean TTP values after Re-186 radiosynovectomy were satisfactory for both ankle and elbow joints.…”

Medical Synovectomy (Synoviorthesis) in Hemophilia: Radiosynovectomy and Chemical Synovectomy

“…However, high radiation doses have not been obtained in peripheral lymphocytes of children (mean age 14.5 ± 2.1 years) who underwent 90 Y RS and, therefore, these data seemed to contradict a high cancer risk [30]. No increase in the risk of cancer has been reported by Infante-Rivard et al after RS [31].…”

Radionuclide Therapy for Bleeding Joints in Hemophilia

“…This study also concluded that blood pool imaging is an objective means for monitoring therapy. Another study by the same author (Türkmen et al 2007) showed that there is no genotoxic effect of the Y-90 colloid on the peripheral blood lymphocytes of 18 boys, therefore contradicting high cancer risk.…”